Restricted blood flow in the brain could be tied to Alzheimer’s
A USC research team has found strong evidence that keeping blood vessels healthy can help prevent cognitive decline.
Training and diversifying the next generation of Alzheimer’s researchers
The inaugural class of the IMPACT-AD program, which is co-directed by a USC professor, will educate 35 professionals at various career stages on conducting more diverse clinical trials.
New research center to address social and economic impacts of Alzheimer’s
USC’s Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease will explore the enormous costs of Alzheimer’s and related dementias.
Dementia-related deaths in the U.S. may be higher than reported
Death certificate data appear to underestimate the true mortality burden of dementia, Alzheimer’s disease and other cognitive impairment, according to a USC-led study.
Targeting these 12 risk factors could prevent or delay almost half of dementia cases
“It’s never too early or too late to take action,” says Lon Schneider of the Keck School of Medicine of USC, co-director of the USC Alzheimer Disease Research Center’s clinical core.
New Alzheimer’s treatments won’t be widely accessible without changes to national health systems
USC research shows how several major countries could prepare their health systems to ensure patients can get Alzheimer’s treatments once they hit the market.
Alzheimer’s gene triggers early breakdowns in blood-brain barrier, predicting cognitive decline
Although scientists have long known APOE4 is a leading risk factor for Alzheimer’s disease, they were unsure how exactly it drives a decline in memory. USC researchers now believe they have an answer.
Certain combinations of cardiovascular drugs may reduce dementia risk
In a first, a USC study has shown that drugs already being used for blood pressure and cholesterol control could provide benefits for Alzheimer’s and other dementias.
Alzheimer’s study aims to see if drug can block brain plaques linked to disease
Keck School of Medicine of USC is launching a large clinical trial that targets amyloid plaques in the brain. The goal: to see whether a drug can clear or slow this plaque in people who have early Alzheimer’s or who appear clinically normal.
As an Alzheimer’s crisis looms, the director of USC’s aging institute focuses on prevention
María Aranda will bring her expertise as a researcher and a social worker to Gov. Gavin Newsom’s Task Force on Alzheimer’s Prevention and Preparedness.
NIH funding for USC Alzheimer’s research grew by more than 400% in 4 years
Funding from the National Institutes of Health — the world’s largest public funder of biomedical research — was $68 million last year, a substantial increase from $13 million in 2015.
Averting Alzheimer’s through exercise, clean air and an active social calendar
November is Alzheimer’s Awareness Month, and USC scientists are researching healthy lifestyle choices and certain drugs that might reduce the risk of developing the disease.
USC study connects air pollution, memory problems and Alzheimer’s-like brain changes
Women in their 70s and 80s who were exposed to fine particle pollution had declines in memory and physical brain changes that were not seen in women who breathed cleaner air.
Facebook Live: The state of Alzheimer’s research
Christian Pike of the USC Leonard Davis School of Gerontology and USC health policy expert Julie Zissimopoulos as they discuss the latest research into the disease.
Alzheimer’s disease impacts women in higher numbers and different ways
As Alzheimer’s Awareness Month begins, USC researchers examine how the disease affects men and women, including theories on estrogen depletion and higher life expectancy.
Scientists propose new approach to Alzheimer’s research to address environmental risks
USC and Duke researchers propose the Alzheimer’s Disease Exposome to address gaps in understanding how environmental factors interact with genetics to increase or reduce risk for the disease.
Tiny region of the brainstem has big effects on brain aging
USC Leonard Davis Professor Mara Mather, co-author of a new study on the locus coeruleus, explains its role in the onset of Alzheimer’s disease and cognitive decline.
Vast majority of dementia patients don’t receive specialty diagnosis or care
A new USC study has found that most older Americans do not meet with a dementia specialist and the use of dementia specialty care is particularly low for Hispanics and Asians.
USC scientists shift goals in Alzheimer’s research to focus on prevention
Amid mounting discoveries about Alzheimer’s complex list of triggers, USC Dornsife researchers turn their attention to preventive measures.
Healthy blood vessels may be the answer to Alzheimer’s prevention
USC research into Alzheimer’s — which will be on display at the upcoming Alzheimer’s Association International Conference — has uncovered much about the disease, including establishing a link between cardiovascular health and a fully functioning brain.
Certain cells secrete a substance that may head off Alzheimer’s, USC study finds
The cells — known as pericytes — preserve neurons in the brain, which can keep dementia and other cognitive disorders at bay.
For Alzheimer’s and dementia patients, thoughtful design can have big impact
New research from a USC professor reinforces the value of designing to maximize natural light, especially for aging adults with a variety of health issues.
Untreated diabetes raises risk of Alzheimer’s disease, study finds
The USC Dornsife research underscores the importance of detecting diabetes and other metabolic diseases in adults as early as possible.
Diet reverses Alzheimer’s-like symptoms in lab model
The findings — focused on components contained in green tea and carrots — lend credence to the idea that certain readily available, plant-based supplements might offer protection against dementia in people.